Securing wider EU commitment to the elimination of hepatitis C virus
H Wedemeyer, TL Tergast, JV Lazarus… - Liver …, 2023 - Wiley Online Library
In 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main
stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV …
stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV …
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO
One of the main goals of the 2016 Global Health Sector Strategy on viral hepatitis is the
elimination of hepatitis C virus (HCV) as a public health problem by 2030, defined as an …
elimination of hepatitis C virus (HCV) as a public health problem by 2030, defined as an …
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a …
Background Highly effective direct-acting antiviral drugs provide the opportunity to eliminate
hepatitis C virus (HCV) infection, but established pathways can be ineffective. We aimed to …
hepatitis C virus (HCV) infection, but established pathways can be ineffective. We aimed to …
[HTML][HTML] Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
ABSTRACT Background & Aims Scale-up of highly-effective direct-acting antivirals (DAAs)
for hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland has led to a …
for hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland has led to a …
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: the ETHOS Engage study
Background Evaluating trends in HCV treatment and prevalence is crucial for monitoring
elimination. We evaluated the change in current infection and treatment among people who …
elimination. We evaluated the change in current infection and treatment among people who …
High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia
Background & Aims High HCV treatment uptake among people at most risk of transmission
is essential to achieve elimination. We aimed to characterise subpopulations of people with …
is essential to achieve elimination. We aimed to characterise subpopulations of people with …
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in …
Background and aims There has been little empirical evidence to show the 'real‐
world'impact of scaling‐up direct‐acting anti‐viral (DAA) treatment among people who inject …
world'impact of scaling‐up direct‐acting anti‐viral (DAA) treatment among people who inject …
Real‐world outcomes of rapid regional hepatitis C virus treatment scale‐up among people who inject drugs in Tayside, Scotland
Summary Background In 2017, Tayside, a region in the East of Scotland, rapidly scaled‐up
Hepatitis C Virus (HCV) outreach and treatment among People Who Inject Drugs (PWID) …
Hepatitis C Virus (HCV) outreach and treatment among People Who Inject Drugs (PWID) …
In search of a 'good number': knowledge controversy and population estimates in the endgame of hepatitis C elimination
We explore the contentious life of a metric used to assess a country's progress in relation to
global disease elimination targets. Our topic is hepatitis C elimination, and our context is …
global disease elimination targets. Our topic is hepatitis C elimination, and our context is …
Nationwide hepatitis C serosurvey and progress towards hepatitis C virus elimination in the country of Georgia, 2021
A Gamkrelidze, S Shadaker, M Tsereteli… - The Journal of …, 2023 - academic.oup.com
Abstract Background The country of Georgia initiated its hepatitis C virus (HCV) elimination
program in 2015, at which point a serosurvey showed the adult prevalence of HCV antibody …
program in 2015, at which point a serosurvey showed the adult prevalence of HCV antibody …